These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 27372176)

  • 21. Diabetic foot ulcers. Pathophysiology, assessment, and therapy.
    Bowering CK
    Can Fam Physician; 2001 May; 47():1007-16. PubMed ID: 11398715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial and Mini-Review: Topical Oxygen Therapy for Diabetic Foot Ulcerations - Avenue Towards New Hope?
    Vas PRJ; Papanas N
    Rev Diabet Stud; 2019; 15():71-73. PubMed ID: 31904758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq.
    Li Y; Ju S; Li X; Li W; Zhou S; Wang G; Cai Y; Dong Z
    Front Endocrinol (Lausanne); 2022; 13():997880. PubMed ID: 36686438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular basis of wound healing in diabetes.
    Brem H; Tomic-Canic M
    J Clin Invest; 2007 May; 117(5):1219-22. PubMed ID: 17476353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
    Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
    Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety evaluation of systemic extremely low frequency magnetic fields used in the healing of diabetic foot ulcers--phase II data.
    Cañedo-Dorantes L; Soenksen LR; García-Sánchez C; Trejo-Núñez D; Pérez-Chávez F; Guerrero A; Cardona-Vicario M; García-Lara C; Collí-Magaña D; Serrano-Luna G; Angeles Chimal JS; Cabrera G
    Arch Med Res; 2015 Aug; 46(6):470-8. PubMed ID: 26226416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds.
    Maione AG; Brudno Y; Stojadinovic O; Park LK; Smith A; Tellechea A; Leal EC; Kearney CJ; Veves A; Tomic-Canic M; Mooney DJ; Garlick JA
    Tissue Eng Part C Methods; 2015 May; 21(5):499-508. PubMed ID: 25343343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem Cells and Angiogenesis: Implications and Limitations in Enhancing Chronic Diabetic Foot Ulcer Healing.
    Rai V; Moellmer R; Agrawal DK
    Cells; 2022 Jul; 11(15):. PubMed ID: 35892584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wound healing and treatments for people with diabetic foot ulcers.
    Jeffcoate WJ; Price P; Harding KG;
    Diabetes Metab Res Rev; 2004; 20 Suppl 1():S78-89. PubMed ID: 15150819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers.
    Eneroth M; van Houtum WH
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S76-80. PubMed ID: 18393328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary wound closure of diabetic foot ulcers by debridement and stitching.
    Ahmed ME; Mohammed MS; Mahadi SI
    J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on pharmacological interventions for diabetic foot ulcers.
    Scimeca CL; Bharara M; Fisher TK; Kimbriel H; Mills JL; Armstrong DG
    Foot Ankle Spec; 2010 Oct; 3(5):285-302. PubMed ID: 20685955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol for treatment of diabetic foot ulcers.
    Brem H; Sheehan P; Boulton AJ
    Am J Surg; 2004 May; 187(5A):1S-10S. PubMed ID: 15147985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wound healing. New modalities for a new millennium.
    Williams RL; Armstrong DG
    Clin Podiatr Med Surg; 1998 Jan; 15(1):117-28. PubMed ID: 9463773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer.
    Lantis JC; Boone D; Gendics C; Todd G
    Adv Skin Wound Care; 2009 Apr; 22(4):167-71. PubMed ID: 19325276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting DNA methylation and demethylation in diabetic foot ulcers.
    Deng JY; Wu XQ; He WJ; Liao X; Tang M; Nie XQ
    J Adv Res; 2023 Dec; 54():119-131. PubMed ID: 36706989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based protocol for diabetic foot ulcers.
    Brem H; Sheehan P; Rosenberg HJ; Schneider JS; Boulton AJ
    Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):193S-209S; discussion 210S-211S. PubMed ID: 16799388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New developments in the treatment of diabetic foot ulcers].
    Bakker K; Schaper NC
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):409-12. PubMed ID: 10719543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular reprogramming of diabetic foot ulcer fibroblasts triggers pro-healing miRNA-mediated epigenetic signature.
    Pastar I; Marjanovic J; Liang L; Stone RC; Kashpur O; Jozic I; Head CR; Smith A; Gerami-Naini B; Garlick JA; Tomic-Canic M
    Exp Dermatol; 2021 Aug; 30(8):1065-1072. PubMed ID: 34114688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus.
    Driver VR; Yao M; Kantarci A; Gu G; Park N; Hasturk H
    Ostomy Wound Manage; 2013 Nov; 59(11):19-26. PubMed ID: 24201169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.